Parkinson’s disease as a system-level disorder

被引:112
|
作者
Caligiore D. [1 ]
Helmich R.C. [2 ,6 ]
Hallett M. [3 ]
Moustafa A.A. [4 ]
Timmermann L. [5 ]
Toni I. [6 ]
Baldassarre G. [1 ]
机构
[1] Laboratory of Computational Embodied Neuroscience (LOCEN), Istituto di Scienze e Tecnologie della Cognizione, Consiglio Nazionale delle Ricerche (ISTC-CNR), Roma
[2] Department of Neurology, Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Nijmegen
[3] National Institute of Neurological Disorders and Stroke (NINDS), Medical Neurology Branch, Bethesda, MD
[4] Western Sydney University, Milperra, NSW
[5] University of Cologne, Cologne
[6] Donders Institute for Brain, Cognition and Behaviour, Nijmegen
关键词
D O I
10.1038/npjparkd.2016.25
中图分类号
学科分类号
摘要
Traditionally, the basal ganglia have been considered the main brain region implicated in Parkinson’s disease. This single area perspective gives a restricted clinical picture and limits therapeutic approaches because it ignores the influence of altered interactions between the basal ganglia and other cerebral components on Parkinsonian symptoms. In particular, the basal ganglia work closely in concert with cortex and cerebellum to support motor and cognitive functions. This article proposes a theoretical framework for understanding Parkinson’s disease as caused by the dysfunction of the entire basal ganglia–cortex–cerebellum system rather than by the basal ganglia in isolation. In particular, building on recent evidence, we propose that the three key symptoms of tremor, freezing, and impairments in action sequencing may be explained by considering partially overlapping neural circuits including basal ganglia, cortical and cerebellar areas. Studying the involvement of this system in Parkinson’s disease is a crucial step for devising innovative therapeutic approaches targeting it rather than only the basal ganglia. Possible future therapies based on this different view of the disease are discussed. © 2016, The Author(s).
引用
收藏
相关论文
共 50 条
  • [1] Studying the System-Level Involvement of MicroRNAs in Parkinson's Disease
    Chatterjee, Paulami
    Bhattacharyya, Malay
    Bandyopadhyay, Sanghamitra
    Roy, Debjani
    [J]. PLOS ONE, 2014, 9 (04):
  • [2] System-Level Analysis of Alzheimer's Disease Prioritizes Candidate Genes for Neurodegeneration
    Brabec, Jeffrey L.
    Lara, Montana Kay
    Tyler, Anna L.
    Mahoney, J. Matthew
    [J]. FRONTIERS IN GENETICS, 2021, 12
  • [3] System-level assertions: approach for electronic system-level verification
    Sohofi, Hassan
    Navabi, Zainalabedin
    [J]. IET COMPUTERS AND DIGITAL TECHNIQUES, 2015, 9 (03): : 142 - 152
  • [4] Is Parkinson's disease a prion disorder?
    Olanow, C. Warren
    Prusiner, Stanley B.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (31) : 12571 - 12572
  • [5] Parkinson's Disease: A Multisystem Disorder
    Helena Nunes Costa
    Ana Raquel Esteves
    Nuno Empadinhas
    Sandra Morais Cardoso
    [J]. Neuroscience Bulletin, 2023, 39 : 113 - 124
  • [6] Parkinson's disease is a neuropsychiatric disorder
    Agid, Y
    Arnulf, I
    Bejjani, P
    Bloch, F
    Bonnet, AM
    Damier, P
    Dubois, B
    François, C
    Houeto, JL
    Iacono, D
    Karachi, C
    Mesnage, V
    Messouak, O
    Vidailhet, M
    Welter, ML
    Yelnik, J
    [J]. PARKINSON'S DISEASE, 2003, 91 : 365 - 370
  • [7] Is Parkinson's disease a lysosomal disorder?
    Klein, Andres D.
    Mazzulli, Joseph R.
    [J]. BRAIN, 2018, 141 : 2255 - 2262
  • [8] Parkinson's disease: A circuit disorder
    DeLong, MR
    Wichmann, T
    [J]. MOVEMENT DISORDERS, 2006, 21 : S44 - S44
  • [9] Parkinson’s disease as a multisystem disorder
    Lisa Klingelhoefer
    H. Reichmann
    [J]. Journal of Neural Transmission, 2017, 124 : 709 - 713
  • [10] PARKINSON'S DISEASE Disorder in the court
    Alderson, T. Reid
    Bax, Ad
    [J]. NATURE, 2016, 530 (7588) : 38 - 39